ScrutarSign up free

UNH SEC Filings

SEC filings for UNH. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.

FormFiledAccession
8-KOct 13, 2026EDGAR
8-KSep 8, 2026EDGAR
8-KAIUnitedHealth Group announced its second quarter 2026 financial results via press release on July 16, 2026, filed under Item 2.02 of Form 8-K.Jul 16, 2026EDGAR
8-KJun 5, 2026EDGAR
8-KMay 11, 2026EDGAR
8-KAIUnitedHealth Group announced its first quarter 2026 financial results via press release on April 21, 2026, filed under Item 2.02 of Form 8-K.Apr 21, 2026EDGAR
8-KMar 9, 2026EDGAR
8-KMar 2, 2026EDGAR
8-KAIUnitedHealth Group's Compensation Committee amended a stock option previously granted to Stephen Hemsley on May 14, 2025, adding a two-year post-vesting share holding requirement.Feb 25, 2026EDGAR
8-KAIUnitedHealth Group announced its fourth quarter and full year 2025 financial results via press release on January 27, 2026.Jan 27, 2026EDGAR
8-KAIOn January 12, 2026, UnitedHealth Group's senior management reaffirmed its previously disclosed adjusted 2025 earnings per share expectations during investor meetings.Jan 12, 2026EDGAR
8-KAIUnitedHealth Group appointed Scott Gottlieb, M.D., former FDA Commissioner, as an independent director effective immediately on November 18, 2025.Nov 21, 2025EDGAR
8-KAIUnitedHealth Group's Board approved a minor amendment to the Company's Amended and Restated Bylaws, effective November 6, 2025, solely to update the registered office and registered agent in Delaware.Nov 13, 2025EDGAR
8-KNov 7, 2025EDGAR
8-KAIUnitedHealth Group announced its third quarter 2025 financial results via press release on October 28, 2025.Oct 28, 2025EDGAR

SEC filings for companies related to UNH

Never miss a UNH filing.

Get an email when UNH files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Source: SEC EDGAR.